Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0009 (900.00%)
At close: Feb 20, 2026
Eastgate Biotech Revenue
Eastgate Biotech had revenue of $23.14K in the quarter ending September 30, 2017. This brings the company's revenue in the last twelve months to $137.64K, up 45,325.08% year-over-year.
Revenue (ttm)
137.64K
Revenue Growth
+45,325.08%
P/S Ratio
7.69
Revenue / Employee
45.88K
Employees
3
Market Cap
1.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 132.03K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sorrento Therapeutics | 64.27M |
| Evofem Biosciences | 17.73M |
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| International Stem Cell | 9.39M |
| Scorpius Holdings | 1.72M |
| THC Farmaceuticals | 18.52K |
| Halberd | 6.94K |